These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7238955)

  • 81. Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells.
    Mårtensson C; Kristensson K; Kalliomäki S; Borrebaeck CA; Carlsson R
    Immunology; 1994 Oct; 83(2):171-9. PubMed ID: 7835932
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent leukocytes.
    Dobaczewska H
    Neoplasma; 1982; 29(3):323-5. PubMed ID: 7133227
    [No Abstract]   [Full Text] [Related]  

  • 83. The role of macrophages in endothelial cell injury--a possible mechanism for delayed xenograft rejection.
    Fryer JP; Chen S; Johnson EM; Simone P; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):626. PubMed ID: 8623310
    [No Abstract]   [Full Text] [Related]  

  • 84. Rat endothelial cells induce selective proliferation of CD8-positive xenogeneic lymphocytes.
    Baron C; Palomera S; Bierre V; Vogt B; Chopin D; Lang P
    Transplant Proc; 1995 Aug; 27(4):2482-3. PubMed ID: 7652896
    [No Abstract]   [Full Text] [Related]  

  • 85. [Specifics anti-tumor immunity induced by gene immunization with ectopic hCGbeta encoding gene].
    Wang LX; Wu J; Guan QD; Xiong SD
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):316-9. PubMed ID: 12921555
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Expression and function of beta 1 integrins on adherent and nonadherent Ehrlich ascites tumor cells.
    Song Z; Varani J; Goldstein IJ
    Exp Cell Res; 1995 May; 218(1):96-104. PubMed ID: 7537699
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [The duration of the inhibitory influence of antironidase serum and its gamma-globulin fraction on the mitotic ACTIVITY OF TUMOR CELLS].
    Sukhorukikh SV
    Biull Eksp Biol Med; 1965 Nov; 60(11):96-8. PubMed ID: 4164707
    [No Abstract]   [Full Text] [Related]  

  • 88. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A kinetic aspect of the antibody production against Ehrlich tumor cells in mice bearing Ehrlich solid tumor.
    Kaneko Y; Nitta K; Umezawa H
    Gan; 1975 Oct; 66(5):573-5. PubMed ID: 1220993
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Effect oh millimeter waves on the immune system in mice with experimental tumors].
    Novoselova EG; Ogaĭ VB; Sinotova OA; Glushkova OV; Sorokina OV; Fesenko EE
    Biofizika; 2002; 47(5):933-42. PubMed ID: 12397969
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Tolerance induction by passage of the antigen with tumor cells].
    Bundschuh G
    Radiobiol Radiother (Berl); 1983; 24(4):525-30. PubMed ID: 6647799
    [No Abstract]   [Full Text] [Related]  

  • 92. [Antineoplastic immunological reactions in animals with Ehrlich's carcinoma].
    Bergamini G; D'Acunzo L; Fazio G; Giudici G
    Riv Patol Clin Sper; 1967; 8(4):477-88. PubMed ID: 5605966
    [No Abstract]   [Full Text] [Related]  

  • 93. [Effect of donor splenic lymphocytes treated with carbon tetrachloride on liver mitotic activity and alpha-fetoprotein production in syngeneic recipients].
    Shipova LIa; Poltoranina VS; Suslov AP
    Biull Eksp Biol Med; 1982 Jun; 93(6):99-101. PubMed ID: 6180783
    [No Abstract]   [Full Text] [Related]  

  • 94. [Effect of an antiserum to splenocyte proteins on the development of an immune response in a toxic lesion of the liver in rats].
    Konoplia AI; Prokopenko LG
    Patol Fiziol Eksp Ter; 1988; (5):45-8. PubMed ID: 3217152
    [No Abstract]   [Full Text] [Related]  

  • 95. Use of Ehrlich's ascitic tumour cells in preparing hyperimmune fluid against third component (C3) of human serum complement.
    Gupta AK; Rao KM; Manja KS
    Indian J Exp Biol; 1980 May; 18(5):532-3. PubMed ID: 6776040
    [No Abstract]   [Full Text] [Related]  

  • 96. Cellular antibody in mice bearing Ehrlich cancer. I. A quantitative study on antitumor activity of cellular antibody in vitro.
    Hara S
    Acta Med Okayama (1952); 1965 Apr; 19(2):91-8. PubMed ID: 4221891
    [No Abstract]   [Full Text] [Related]  

  • 97. [Natural resistance and induced resistance to ATPC + tumor in mice].
    Marconi P; Pitzurra M; Bistoni F; Iorio A
    Boll Ist Sieroter Milan; 1972; 51(1):27-43. PubMed ID: 5083003
    [No Abstract]   [Full Text] [Related]  

  • 98. Heterologous antisera against specific HL-A antigens.
    Einstein AB; Mann DL; Gordon HG; Trapani RJ; Fahey JL
    Transplantation; 1971 Oct; 12(4):299-304. PubMed ID: 4107112
    [No Abstract]   [Full Text] [Related]  

  • 99. Cellular antibody in mice bearing Ehrlich cancer. II. Properties of lymphoid cells from sensitized animal.
    Hara S
    Acta Med Okayama (1952); 1965 Apr; 19(2):99-106. PubMed ID: 4221944
    [No Abstract]   [Full Text] [Related]  

  • 100. [Effect of passively administered antibodies on the development of Ehrlich tumor in mice].
    Strzelecka G
    Ann Acad Med Stetin; 1980; 26():387-400. PubMed ID: 7186780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.